Sariant Therapeutics Inc is currently the only software provider that can automatically resolve complex cancer genomes and find cancer-specific DNA foldings induced by structural variance. We use modern machine-learning technology to identify high-resolution DNA fusion events and actionable elements that are essential to cancerogenesis. Sariant software products can help drug companies successfully test and develop new targeted medicines to treat various types of cancer.

More product information will be released soon.